Long QT Syndrome News and Research

RSS
Long QT syndrome (LQTS) is a disease that affects the normal heart rhythm and electrical activity. It may lead to sudden onset and dangerous arrhythmias (irregularities of heart rate and rhythm) which may be brought on by triggers like exercise or stress.
FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Scientists figure out way to measure fetal cardiac electrical activity

Scientists figure out way to measure fetal cardiac electrical activity

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

VTCRI scientist receives new federal grant for research into a heart mutation

VTCRI scientist receives new federal grant for research into a heart mutation

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Combining stem cell technology and artificial intelligence to diagnose genetic cardiac diseases

Combining stem cell technology and artificial intelligence to diagnose genetic cardiac diseases

Genomic science can help healthcare professionals to identify, treat inherited cardiac conditions

Genomic science can help healthcare professionals to identify, treat inherited cardiac conditions

Genetic heart mutations account for fewer sudden and unexplained infant deaths

Genetic heart mutations account for fewer sudden and unexplained infant deaths

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Energy drinks linked to risk of cardiac events in young people with familial long QT syndrome

Energy drinks linked to risk of cardiac events in young people with familial long QT syndrome

FDA grants approval for first drug to treat adults with tardive dyskinesia

FDA grants approval for first drug to treat adults with tardive dyskinesia

New report reveals optimal way to detect young athletes at risk of sudden cardiac death

New report reveals optimal way to detect young athletes at risk of sudden cardiac death

Heart specialists to examine benefit of ECG screening for student athletes

Heart specialists to examine benefit of ECG screening for student athletes

Research shows clear link between heart and the brain of LQTS patients

Research shows clear link between heart and the brain of LQTS patients

Genetic testing worthwhile in sudden cardiac death

Genetic testing worthwhile in sudden cardiac death

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Study: Blackouts, near drownings linked to sudden death risk

Study: Blackouts, near drownings linked to sudden death risk

Researchers find way to predict occurrence of some cardiac arrhythmias

Researchers find way to predict occurrence of some cardiac arrhythmias

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer